Today at 1:05pm CST / 2:05 pm EST on The Traders Network with Host Michael Yorba

NEW YORK, NY–(Feb 12, 2014) – NeoStem, Inc. (NASDAQ: NBS) (“NeoStem”), a leader in the emerging cellular therapy industry, today announced that Chairman and CEO Dr. Robin L. Smith will be interviewed live today by host Michael Yorba on Clear Channel Business Talk Radio’s The Traders Network. All investors, analysts, industry professionals and prospective customers that are interested to learn more about NeoStem, its goals and recent developments are invited to tune in and listen live via Clear Channel’s nationally syndicated iHeart Radio stream.

 

The interview will air today, Wednesday, February 12, 2014 at 1:05pm U.S. CST / 11:05am PST / 2:05pm EST on Clear Channel DFW 1190AM.

 

Live iHeart Radio Stream: http://www.iheart.com/live/4276/?autoplay=true
Time: 1:05pm CST | 11:05pm PST | 2:05pm EST (U.S.)
Date: February 12, 2014
Network: Clear Channel
Station: DFW 1190AM
Host: Michael Yorba

 

About Clear Channel: Clear Channel Media and Entertainment’s more than 840 radio stations offer programming nationwide. Individual station brands connect with diverse audiences in local markets across the country reaching more than 112 million listeners. www.clearchannel.com.

 

About Michael Yorba: Mr. Yorba is the founder of Yorba Media and featured host on Clear Channel’s DFW 1190AM in Dallas-Ft. Worth, TX. For the past six years he has been integrally involved with producing and hosting a daily talk show called Commodity Classics, and The Traders Network.

From the fast action of the trading pit… to the power brokers making the headlines… Michael Yorba interviews the front-page Titans about the latest in capital markets, CEO milestones, trading tools and market trends. Learn how the experts use risk management techniques to build fully diversified portfolios and what it takes to put up big board earnings. It’s a fast moving, high-energy show that presents stocks, commodities, bonds, forex, derivatives, political trends, crowd funding and impact investment insights in a new light and keeps investors and consumers asking for more… The Traders Network stays ahead of the curve by featuring leading market and business professionals, sophisticated technology, and the analytics needed to identify the most lucrative investment strategies. Successful performance depends on finding the right opportunities. So… shift your thinking and join us as we deliver “tomorrow’s ideas today” on Clear Channel’s the Traders Network Monday – Friday from 1:00pm – 3:00pm CST live after Glenn Beck.

 

About NeoStem: NeoStem, Inc. is a leader in the emerging cellular therapy industry. Our business model includes the development of novel proprietary cell therapy products as well as operating a contract development and manufacturing organization providing services to others in the regenerative medicine industry. The combination of a therapeutic development business and revenue-generating service provider business provides the Company with capabilities for cost effective in-house product development and immediate revenue and cash flow generation. www.neostem.com

 

Forward-Looking Statements: This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management’s current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company’s business strategy, including with respect to the Company’s research and development and clinical evaluation efforts as well as efforts towards commercialization of cellular therapies, including with respect to AMR-001, the future of the regenerative medicine industry and the role of stem cells and cellular therapy in that industry and the Company’s ability to successfully grow its contract development and manufacturing business. The Company’s actual results could differ materially from those anticipated in these forward- looking statements as a result of various factors. Factors that could cause future results to materially differ from the recent results or those projected in forward-looking statements include the “Risk Factors” described in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 11, 2013 and in the Company’s periodic filings with the SEC. The Company’s further development is highly dependent on future medical and research developments and market acceptance, which is outside its control.

 

A CommPro Worldwide PR Event

 

Contacts:

 

PR & Media Contact:

Matt Bird, CEO
CommPro Worldwide

C: +1 (646) 401-4499
E: matt.bird@commpro.com